Search - tctmd.com

Displaying 561 - 580 of 1394

Presentation TCT 2018

Case #10: A Case Demonstrating the Resting Full-Cycle Ratio (RFR)

Presenter: Justin E. Davies, Javier Escaned, Felix Bohm, Matthias Götberg, Michalis Hamilos, Niels R. Holm, Erick Schampaert, Adhir Shroff

September 23, 2018

Presentation TCT 2018

Case #9: A Case in Which it Was Preferable To Measure Coronary Flow, Not Pressure

Presenter: Justin E. Davies, Javier Escaned, Felix Bohm, Matthias Götberg, Michalis Hamilos, Niels R. Holm, Erick Schampaert, Adhir Shroff

September 23, 2018

Presentation TCT 2018

Case #8: A Case of Culprit and Non-Culprit Lesion Assessment in ACS: FFR, iFR, Both or Nither?

Presenter: Justin E. Davies, Javier Escaned, Felix Bohm, Matthias Götberg, Michalis Hamilos, Niels R. Holm, Erick Schampaert, Adhir Shroff

September 23, 2018

Presentation TCT 2018

Case #7: A Case With Marked Discordance Between FFR and iFR Which to Believe?

Presenter: Justin E. Davies, Javier Escaned, Felix Bohm, Matthias Götberg, Michalis Hamilos, Niels R. Holm, Erick Schampaert, Adhir Shroff

September 23, 2018

Presentation TCT 2018

Case #6: A Case of FFR and iFR in the Left Main Which To Believe?

Presenter: Justin E. Davies, Javier Escaned, Felix Bohm, Matthias Götberg, Michalis Hamilos, Niels R. Holm, Erick Schampaert, Adhir Shroff

September 23, 2018

Presentation TCT 2018

Case #5: A Case of iFR Co-Registration To Identify Focal Treatable Disease

Presenter: Justin E. Davies, Javier Escaned, Felix Bohm, Matthias Götberg, Michalis Hamilos, Niels R. Holm, Erick Schampaert, Adhir Shroff

September 23, 2018

Presentation TCT 2018

Case #4: A Case in Which Post-Stent FFR Assessment Changed My Treatment

Presenter: Justin E. Davies, Javier Escaned, Felix Bohm, Matthias Götberg, Michalis Hamilos, Niels R. Holm, Erick Schampaert, Adhir Shroff

September 23, 2018

Presentation TCT 2018

Case #3: A Case in Which FFR Of A Mild Lesion Led Me To Stent

Presenter: Justin E. Davies, Javier Escaned, Felix Bohm, Matthias Götberg, Michalis Hamilos, Niels R. Holm, Erick Schampaert, Adhir Shroff

September 23, 2018

Presentation TCT 2018

Case #2: A Case in Which 3-Vessel FFR Markedly Changed My Treatment

Presenter: Justin E. Davies, Javier Escaned, Felix Bohm, Matthias Götberg, Michalis Hamilos, Niels R. Holm, Erick Schampaert, Adhir Shroff

September 23, 2018

Presentation TCT 2018

Case #1: A Case of Physiological Assessment of a Myocardial Bridge

Presenter: Justin E. Davies, Javier Escaned, Felix Bohm, Matthias Götberg, Michalis Hamilos, Niels R. Holm, Erick Schampaert, Adhir Shroff

September 23, 2018

Presentation TCT 2018

EFS Experiences Grom the Industry Client Perspective: Whats Good and What Needs to Change?

Presenter: Andrew Farb, Martin B. Leon, Donald E. Bobo Jr

September 22, 2018

Presentation TCT 2018

EFS Decisions: Start-up Company Considerations

Presenter: Andrew Farb, Martin B. Leon, Beverly A Huss

September 22, 2018

Presentation TCT 2018

Promoting Medical Device Innovation: MDIC Perspectives

Presenter: Andrew Farb, Martin B. Leon, Liz McDermott

September 22, 2018

Presentation TCT 2018

The Second-Generation Cardiovascular EFS Pilot: Progress Report

Presenter: Andrew Farb, Martin B. Leon, David R. Holmes Jr.

September 22, 2018

Presentation TCT 2018

The US EFS Program: FDA Update

Presenter: Andrew Farb, Martin B. Leon

September 22, 2018

Presentation TCT 2018

Industry Perspective

Presenter: C. Michael Gibson, William H. Maisel, Campbell Rogers

September 22, 2018

Presentation TCT 2018

Clinician Scientist/Trialist Perspective

Presenter: C. Michael Gibson, William H. Maisel, James K. Min

September 22, 2018

Presentation TCT 2018

FDA Perspectives

Presenter: C. Michael Gibson, William H. Maisel, Mohua Choudhury

September 22, 2018

Presentation TCT 2018

Keynote Lecture: The Potential Impact of Machine Learning/Artificial Intelligence on Cardiovascular Medical Device Development

Presenter: C. Michael Gibson, William H. Maisel, Peter J. Fitzgerald

September 22, 2018

Presentation TCT 2018

CMS Perspectives

Presenter: Lori M Ashby

September 22, 2018

Advertisement

Case #10: A Case Demonstrating the Resting Full-Cycle Ratio (RFR)

Case #9: A Case in Which it Was Preferable To Measure Coronary Flow, Not Pressure

Case #8: A Case of Culprit and Non-Culprit Lesion Assessment in ACS: FFR, iFR, Both or Nither?

Case #7: A Case With Marked Discordance Between FFR and iFR Which to Believe?

Case #6: A Case of FFR and iFR in the Left Main Which To Believe?

Case #5: A Case of iFR Co-Registration To Identify Focal Treatable Disease

Case #4: A Case in Which Post-Stent FFR Assessment Changed My Treatment

Case #3: A Case in Which FFR Of A Mild Lesion Led Me To Stent

Case #2: A Case in Which 3-Vessel FFR Markedly Changed My Treatment

Case #1: A Case of Physiological Assessment of a Myocardial Bridge

EFS Experiences Grom the Industry Client Perspective: Whats Good and What Needs to Change?

EFS Decisions: Start-up Company Considerations

Promoting Medical Device Innovation: MDIC Perspectives

The Second-Generation Cardiovascular EFS Pilot: Progress Report

The US EFS Program: FDA Update

Industry Perspective

Clinician Scientist/Trialist Perspective

FDA Perspectives

Keynote Lecture: The Potential Impact of Machine Learning/Artificial Intelligence on Cardiovascular Medical Device Development

CMS Perspectives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content